AbbVie 'Concocted' Cancer Drug IP Claims, Biotech Firm Says

By Ben Adlin · August 28, 2026, 9:27 PM EDT

Biotech firms ProfoundBio and Genmab urged a Seattle federal judge Thursday to throw out rival AbbVie's lawsuit accusing two of its former employees of taking trade secrets on cancer therapies to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

AbbVie Inc. v. Genmab A/S et al

Case Number

2:25-cv-00510

Court

Washington Western

Nature of Suit

Defend Trade Secrets Act (of 2016)

Date Filed

March 21, 2025